Episoder
-
In this episode, we explore the use of atypical antipsychotics during pregnancy for women with bipolar disorder. We discuss recent research findings, potential risks, and the delicate balance between managing maternal mental health and fetal safety. How do clinicians approach this challenging clinical decision?
Faculty: Vivien Burt, M.D.
Learn more about our memberships here Earn 1 CME: Perinatal Treatment of Bipolar Disorder Risks of Using Antipsychotics During Pregnancy
Host: Richard Seeber, M.D. -
In this episode, we explore the use of risperidone in treating anorexia nervosa in children and adolescents. We discuss a groundbreaking study examining its efficacy and tolerability. Can atypical antipsychotics like risperidone offer hope for young anorexia patients, or are we still searching for effective pharmacological treatments?
Faculty: David Rosenberg, M.D.
Learn more about our membership here Earn 0.5 CME: CAP Smart Takes Vol. 18 Efficacy of Risperidone as Treatment for Anorexia Nervosa
Host: Richard Seeber, M.D. -
Mangler du episoder?
-
In this episode, we explore the complexities of managing lithium during pregnancy for women with bipolar disorder. How do lithium levels change throughout pregnancy, and what monitoring is necessary? We discuss dosing strategies, fetal monitoring, and postpartum considerations to ensure the best outcomes for both mother and baby.
Faculty: Vivien Burt, M.D.
Learn more about our memberships here Earn 1 CME: Perinatal Treatment of Bipolar Disorder Bipolar Disorder During Pregnancy: Management of Lithium
Host: Richard Seeber, M.D. -
In this episode, we explore the revolutionary potential of daridorexant, a new dual orexin receptor antagonist (DORA) for treating chronic insomnia. We discuss its unique mechanism of action, efficacy, and implications for future insomnia treatment. Could this medication be the key to "turning off" wakefulness in stubborn cases of insomnia?
Faculty: Carlos H. Schenck, M.D.
Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 58 Use of Daridorexant for the Management of Chronic Insomnia
Host: Richard Seeber, M.D. -
In this episode, we explore the risks and benefits of using lithium during pregnancy for women with bipolar disorder. We discuss recent research on cardiac malformations and dose-dependent risks. Is the fear of lithium use in pregnancy justified by the latest evidence?
Faculty: Vivien Burt, M.D.
Learn more about our memberships here Earn 1 CME: Perinatal Treatment of Bipolar Disorder Risks of Using Lithium in Pregnancy
Host: Richard Seeber, M.D. -
In this episode, we explore a groundbreaking study on escitalopram's efficacy in treating generalized anxiety disorder in children and adolescents. We discuss its potential as the first FDA-approved medication for youth anxiety. How might this change our approach to pediatric anxiety treatment?
Faculty: David Rosenberg, M.D.
Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 18 The Role of Escitalopram in Treating Generalized Anxiety Disorder in Youth
Host: Richard Seeber, M.D. -
In this episode, we explore psychodynamic psychopharmacology and its role in addressing treatment-resistant cases. We discuss how patient-doctor relationships, transference, and countertransference can impact medication effectiveness. How might your own unconscious biases influence your prescribing decisions?
Faculty: David Mintz, M.D.
Learn more about our memberships here Earn 1.75 CME: Psychodynamic Psychopharmacology: From Biomedical Approaches to Patient Relationships Cultivating a Therapeutic Alliance
Host: Richard Seeber, M.D. -
In this episode, we explore the therapeutic potential of psychedelic compounds in psychiatry. We discuss their definition, mechanism of action, and potential uses in treating anxiety and depression. How might psychedelics reshape the future of psychopharmacology?
Faculty: Sidney LeFay, D.O.
Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 58 Psychedelics as Transformative Therapeutics
Host: Richard Seeber, M.D. -
In this episode, we explore the concept of patient ambivalence in psychopharmacology. How can understanding a patient's conflicting feelings about treatment improve outcomes? We discuss strategies for recognizing and addressing ambivalence, and its impact on medication adherence and effectiveness.
Faculty: David Mintz, M.D.
Learn more about our memberships here Earn 1.75 CME: Psychodynamic Psychopharmacology: From Biomedical Approaches to Patient Relationships Attending the Patient’s Ambivalence
Host: Richard Seeber, M.D. -
In this episode, we explore vaping cessation methods used by US adolescent e-cigarette users. We discuss a study analyzing the prevalence and effectiveness of various quitting strategies, considering factors like demographics and perception of harm. How can healthcare providers tailor their approach to help teens quit vaping?
Faculty: David Rosenberg, M.D.
Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 17 Adoption of Vaping Cessation Methods by U.S. Adolescents
Host: Richard Seeber, M.D. -
In this episode, we explore Psychodynamic Psychopharmacology, an innovative approach to treating medication-resistant patients. We discuss how psychological factors influence drug responses and learn techniques to enhance treatment outcomes. Could understanding the meaning patients attach to their medications be the key to unlocking treatment resistance?
Faculty: David Mintz, M.D.
Learn more about our memberships here Earn 1.75 CME: Psychodynamic Psychopharmacology: From Biomedical Approaches to Patient Relationships An Introduction to Psychodynamic Psychopharmacology
Host: Richard Seeber, M.D. -
In this episode, we explore the complex relationship between benzodiazepine use and suicide risk, examining a groundbreaking French study that challenges our understanding of this connection. Is our go-to anxiety treatment potentially increasing suicide risk?
Faculty: Paul Zarkowski, M.D.
Learn more about our membership here Earn 0.5 CMEs: Quick Take Vol. 57 Risk for Suicide Attempts and Suicide Associated With Benzodiazepines
Host: Richard Seeber, M.D. -
In this episode, we explore how a psychodynamic approach can shed light on treatment-resistant cases. Can understanding a patient's psychological dynamics be the key to unlocking better outcomes?
Faculty: David Mintz, M.D.
Learn more about our memberships here Earn 1.75 CME: Psychodynamic Psychopharmacology: From Biomedical Approaches to Patient Relationships Understanding the Problem of Treatment Resistance
Host: Richard Seeber, M.D. -
In this episode, we explore the fascinating connection between ADHD, pain sensitivity, and methylphenidate treatment in children. Could methylphenidate help reduce pain sensitivity in pediatric ADHD patients?
Faculty: David Rosenberg, M.D.
Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 17 Effect of Methylphenidate on Pain Perception Thresholds in Children With ADHD
Host: Richard Seeber, M.D. -
In this episode, we dive into the complex world of treating insomnia in patients with major depressive disorder. What's the best approach to help these patients find restful sleep and improve their mood? Join us as we explore a range of strategies, from medication to behavioral interventions.
Faculty: Amit Chopra, M.D.
Learn more about our memberships here Earn 1.25 CME: Navigating Insomnia in Major Depressive Disorder: Advances in Management Treatment Strategies for Managing Insomnia in MDD
Host: Richard Seeber, M.D. -
In this episode, we explore the latest pharmacologic interventions for managing insomnia in patients with major depressive disorder. Can dual orexin receptor antagonists, melatonin agonists, and low-dose doxepin provide relief for those struggling with sleep? Join us as we discuss the advances in treating insomnia and depression.
Faculty: Amit Chopra, M.D.
Learn more about our memberships here Earn 1.25 CMEs: Navigating Insomnia in Major Depressive Disorder: Advances in Management Other Pharmacologic Interventions for Insomnia
Host: Richard Seeber, M.D. -
In this episode, we explore the potential of fish oil as an adjunct to cognitive–behavioral therapy for treating depression in youth. Can this combination enhance treatment outcomes, or is cognitive–behavioral therapy alone just as effective? Join us as we dive into this intriguing study.
Faculty: David Rosenberg, M.D.
Learn more about our membership here Earn 0.5 CMEs: CAP Smart Takes Vol. 16 Is Fish Oil Effective in Youth Depression?
Host: Richard Seeber, M.D. -
In this episode, we explore the use of benzodiazepines and nonbenzodiazepine hypnotics for managing insomnia in major depressive disorder. How do these medications work, and what are the key considerations when prescribing them? Join us as we navigate the complexities of pharmacologic interventions for insomnia.
Faculty: Amit Chopra, M.D.
Learn more about our memberships here Earn 1.25 CME: Navigating Insomnia in Major Depressive Disorder: Advances in Management Pharmacologic Interventions for Insomnia: Benzodiazepines and Non-Benzodiazepine Hypnotics
Host: Richard Seeber, M.D. -
In this episode, we explore the safety of antipsychotics in patients with liver disease. How can psychiatrists navigate the risk–benefit balance when treating medically complex individuals? Dr. Sydney LeFay discusses key insights from a recent review article, guiding antipsychotic selection and monitoring.
Faculty: Sydney LeFay, D.O.
Learn more about our membership here Earn 0.75 CMEs: Quick Take Vol. 56 Antipsychotic Safety in Liver Disease
Host: Richard Seeber, M.D. -
In this episode, we explore the complex relationship between insomnia and major depressive disorder. How does insomnia impact the course and treatment of depression? Join us as we dive into the neurobiology and clinical implications of this fascinating topic with expert Dr. Amit Chopra.
Faculty: Amit Chopra, M.D.
Learn more about our memberships here Earn 1.25 CME: Navigating Insomnia in Major Depressive Disorder: Advances in Management Understanding the Relationship Between Insomnia Disorder and MDD
Host: Richard Seeber, M.D. - Se mer